Altimmune (ALT) Prepaid Assets (2010 - 2026)
Altimmune (ALT) reported Prepaid Assets of $1.4 million for Q1 2026, down 51.23% year-over-year from $2.9 million in Q1 2025, and down 51.67% quarter-over-quarter from $3.0 million in Q4 2025.
Altimmune (ALT) Prepaid Assets (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 17 years of Prepaid Assets data on file, last reported at $1.4 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $1.4 million, down 51.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (down 51.23% YoY), and the FY2025 annual result was $3.0 million, up 34.17% from the prior year.
- Prepaid Assets slipped to $1.4 million in Q1 2026 per ALT's latest filing, from $3.0 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $7.6 million in Q3 2023 and troughed at $1.4 million in Q1 2026.
- A 5-year average of $4.2 million and a median of $4.4 million in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets soared 58.98% in 2023, then sank 68.14% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $5.4 million in 2022, then climbed by 29.1% to $6.9 million in 2023, then slumped by 68.14% to $2.2 million in 2024, then jumped by 34.17% to $3.0 million in 2025, then tumbled by 51.67% to $1.4 million in 2026.
- Business Quant data shows ALT's Prepaid Assets at $1.4 million in Q1 2026, $3.0 million in Q4 2025, and $4.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.43 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Sep 30, 2025 | 4.41 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Mar 31, 2025 | 2.93 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Mar 31, 2024 | 2.87 Mn |
| Dec 31, 2023 | 6.92 Mn |
| Sep 30, 2023 | 7.62 Mn |
| Jun 30, 2023 | 5.82 Mn |
| Mar 31, 2023 | 3.98 Mn |
| Dec 31, 2022 | 5.36 Mn |
| Sep 30, 2022 | 4.79 Mn |
| Jun 30, 2022 | 4.62 Mn |
| Mar 31, 2022 | 5.04 Mn |
| Dec 31, 2021 | 7.95 Mn |
| Sep 30, 2021 | 7.29 Mn |
| Jun 30, 2021 | 9.41 Mn |